Chargement en cours...
Choosing first line therapy for chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) exhibits a highly variable natural history, but the addition of genomic risk stratification to traditional clinical staging systems has begun to explain the heterogeneous clinical course. Overall response to treatment has significantly improved over the past three...
Enregistré dans:
| Publié dans: | Expert Rev Anticancer Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341916/ https://ncbi.nlm.nih.gov/pubmed/21929312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.11.132 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|